NEOGENOMICS INC (NEO) Stock Earnings & Estimates
NASDAQ:NEO - US64049M2098 - Common Stock
7.1 USD
+0.02 (+0.28%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 509.7M 5.24% | 591.643M 16.08% | 660.566M 11.65% | 729.25M 10.40% | 802.96M 10.11% | 878.77M 9.44% | 931.62M 6.01% | 1.006B 7.98% | 1.561B 55.17% | |
| EBITDA YoY % growth | -83.67M -68.18% | -24.065M 71.24% | -12.901M 46.39% | 44.787M 447.16% | 61.041M 36.29% | 80.825M 32.41% | 136.35M 68.70% | 163.22M 19.71% | N/A | |
| EBIT YoY % growth | -153.1M -48.50% | -96.648M 36.87% | -85.448M 11.59% | -115.822M -35.55% | -79.263M 31.56% | -34.528M 56.44% | -41.915M -21.39% | -25.149M 40.00% | 234.15M 1,031.05% | |
| Operating Margin | -30.04% | -16.34% | -12.94% | -15.88% | -9.87% | -3.93% | -4.50% | -2.50% | 15.00% | |
| EPS YoY % growth | -0.56 -107.41% | -0.11 80.36% | 0.10 190.91% | 0.09 -8.02% | 0.18 97.57% | 0.40 117.93% | 0.69 73.41% | 0.83 20.59% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.02 -53.12% | 0.05 19.03% | 0.01 | 0.05 59.55% | 0.07 193.97% | 0.09 88.14% | 0.07 741.79% | 0.10 101.88% | 0.11 52.43% | 0.12 31.92% |
| Revenue Q2Q % growth | 185.61M 10.60% | 190.67M 10.85% | 190.95M 13.64% | 201.47M 11.11% | 204.85M 10.37% | 210.9M 10.61% | 204.48M 7.09% | 216.5M 7.46% | 220.2M 7.49% | 226.61M 7.45% |
| EBITDA Q2Q % growth | 11.108M -67.49% | 13.641M -75.58% | 9.191M 191.03% | 14.809M 99.99% | 17.196M 54.81% | 19.629M 43.90% | 16.948M 84.40% | 21.226M 43.33% | 22.496M 30.82% | 22.871M 16.52% |
| EBIT Q2Q % growth | -24.271M -20.23% | -20.556M -23.14% | -25.645M 7.83% | -19.784M 28.28% | -15.77M 35.03% | -12.726M 38.09% | -18.626M 27.37% | -13.371M 32.42% | -12.173M 22.81% | -12.317M 3.21% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.03 | 0.02 | 0.01 | 31.60% |
| Q1 2025 Q2Q % growth | 0.00 100.00% | -0.01 | 0.01 | 100.00% |
| Q4 2024 Q2Q % growth | 0.04 33.33% | 0.03 | 0.01 | 35.03% |
| Q3 2024 Q2Q % growth | 0.05 | 0.01 | 0.04 | 298.27% |
| Q2 2024 Q2Q % growth | 0.03 160.00% | 0.00 | 0.03 | 871.51% |
| Q1 2024 Q2Q % growth | -0.02 77.78% | -0.05 | 0.03 | 59.66% |
| Q4 2023 Q2Q % growth | 0.03 150.00% | -0.03 | 0.06 | 219.19% |
| Q3 2023 Q2Q % growth | 0.00 100.00% | -0.08 | 0.08 | 100.00% |
| Q2 2023 Q2Q % growth | -0.05 68.75% | -0.11 | 0.06 | 56.40% |
| Q1 2023 Q2Q % growth | -0.09 55.00% | -0.15 | 0.06 | 41.11% |
| Q4 2022 Q2Q % growth | -0.06 57.14% | -0.17 | 0.11 | 63.95% |
| Q3 2022 Q2Q % growth | -0.14 -75.00% | -0.21 | 0.07 | 32.66% |
| Q2 2022 Q2Q % growth | -0.16 -1,500.00% | -0.23 | 0.07 | 29.71% |
| Q1 2022 Q2Q % growth | -0.20 -400.00% | -0.24 | 0.04 | 15.83% |
| Q4 2021 Q2Q % growth | -0.14 -200.00% | -0.15 | 0.01 | 4.71% |
| Q3 2021 Q2Q % growth | -0.08 -233.33% | -0.09 | 0.01 | 7.45% |
| Q2 2021 Q2Q % growth | -0.01 75.00% | -0.06 | 0.05 | 84.39% |
| Q1 2021 Q2Q % growth | -0.04 -100.00% | 0.01 | -0.05 | -463.01% |
| Q4 2020 Q2Q % growth | 0.14 40.00% | 0.06 | 0.08 | 120.97% |
| Q3 2020 Q2Q % growth | 0.06 -14.29% | 0.04 | 0.02 | 56.33% |
| Q2 2020 Q2Q % growth | -0.04 -157.14% | -0.10 | 0.06 | 61.83% |
| Q1 2020 Q2Q % growth | -0.02 -128.57% | 0.02 | -0.04 | -199.01% |
| Q4 2019 Q2Q % growth | 0.10 | 0.06 | 0.04 | 54.01% |
| Q3 2019 Q2Q % growth | 0.07 | 0.06 | 0.01 | 15.51% |
| Q2 2019 Q2Q % growth | 0.07 | 0.06 | 0.01 | 13.15% |
| Q1 2019 Q2Q % growth | 0.07 | 0.04 | 0.03 | 58.42% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 181.33M 10.23% | 184.52M | -3.19M | -1.73% |
| Q1 2025 Q2Q % growth | 168.035M 7.55% | 172.67M | -4.635M | -2.68% |
| Q4 2024 Q2Q % growth | 172M 10.57% | 174.91M | -2.91M | -1.66% |
| Q3 2024 Q2Q % growth | 167.824M 10.44% | 168.68M | -856K | -0.51% |
| Q2 2024 Q2Q % growth | 164.502M 11.97% | 163.47M | 1.032M | 0.63% |
| Q1 2024 Q2Q % growth | 156.24M 13.86% | 151.39M | 4.85M | 3.20% |
| Q4 2023 Q2Q % growth | 155.552M 12.15% | 154.06M | 1.492M | 0.97% |
| Q3 2023 Q2Q % growth | 151.954M 17.98% | 143.06M | 8.894M | 6.22% |
| Q2 2023 Q2Q % growth | 146.917M 17.44% | 138.8M | 8.117M | 5.85% |
| Q1 2023 Q2Q % growth | 137.22M 17.08% | 127.66M | 9.56M | 7.49% |
| Q4 2022 Q2Q % growth | 138.7M 10.34% | 131.27M | 7.43M | 5.66% |
| Q3 2022 Q2Q % growth | 128.8M 6.18% | 122.75M | 6.05M | 4.93% |
| Q2 2022 Q2Q % growth | 125.1M 2.79% | 124.56M | 540K | 0.43% |
| Q1 2022 Q2Q % growth | 117.2M 1.47% | 117.85M | -650K | -0.55% |
| Q4 2021 Q2Q % growth | 125.7M -0.24% | 127.04M | -1.34M | -1.05% |
| Q3 2021 Q2Q % growth | 121.3M -3.27% | 126.31M | -5.01M | -3.97% |
| Q2 2021 Q2Q % growth | 121.7M 39.89% | 119.16M | 2.54M | 2.13% |
| Q1 2021 Q2Q % growth | 115.5M 8.96% | 113.53M | 1.97M | 1.74% |
| Q4 2020 Q2Q % growth | 126M 17.87% | 125.51M | 490K | 0.39% |
| Q3 2020 Q2Q % growth | 125.4M 19.77% | 127.49M | -2.09M | -1.64% |
| Q2 2020 Q2Q % growth | 87M -14.45% | 87.418M | -418K | -0.48% |
| Q1 2020 Q2Q % growth | 106M 10.88% | 105.63M | 370K | 0.35% |
| Q4 2019 Q2Q % growth | 106.9M | 105.28M | 1.62M | 1.54% |
| Q3 2019 Q2Q % growth | 104.7M | 100.09M | 4.61M | 4.61% |
| Q2 2019 Q2Q % growth | 101.7M | 98.274M | 3.426M | 3.49% |
| Q1 2019 Q2Q % growth | 95.6M | 91.52M | 4.08M | 4.46% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -56.85% | -60.45% | -42.63% | -49.05% |
| Revenue | -4.46% | -2.54% | -3.14% | -3.12% |